101 related articles for article (PubMed ID: 1726240)
1. [Amplification of L-myc oncogene in malignant meningioma. Case report].
Jimbo T; Tsuboi K; Iwamura Y; Kaneko M; Nakagawa K; Nose T
Neurol Med Chir (Tokyo); 1991 Dec; 31(13):1040-4. PubMed ID: 1726240
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a human malignant meningioma cell line with amplified c-myc oncogene.
Tanaka K; Sato C; Maeda Y; Koike M; Matsutani M; Yamada K; Miyaki M
Cancer; 1989 Dec; 64(11):2243-9. PubMed ID: 2804914
[TBL] [Abstract][Full Text] [Related]
3. Enhanced expression of the c-myc protooncogene in human intracranial meningiomas.
Kim JH; Lee SH; Cho KJ; Jang JJ; Hong SI; Lee JH
J Korean Med Sci; 1993 Feb; 8(1):68-72. PubMed ID: 8343222
[TBL] [Abstract][Full Text] [Related]
4. Her-2/neu gene amplification in paraffin-embedded tissue sections of meningioma patients.
Ozer O; Sahin FI; Aydemir F; Ozen O; Yilmaz Z; Altinörs N
Turk Neurosurg; 2009 Apr; 19(2):135-8. PubMed ID: 19431122
[TBL] [Abstract][Full Text] [Related]
5. Correlation of proto-oncogene expression and proliferation and meningiomas.
Detta A; Kenny BG; Smith C; Logan A; Hitchcock E
Neurosurgery; 1993 Dec; 33(6):1065-74. PubMed ID: 8133992
[TBL] [Abstract][Full Text] [Related]
6. Molecular and genetic characterization of meningiomas: future predictive assays and "personalized" treatment.
Elder JB; Chiocca EA
World Neurosurg; 2013 Feb; 79(2):247-8. PubMed ID: 22120235
[No Abstract] [Full Text] [Related]
7. Masked hypodiploidy in anaplastic meningiomas by duplication of the original clone found in atypical meningiomas: illustration of the evolution of genetic alterations.
Ely EE; Guzman MA; Calvey LS; Batanian JR
Neuropathology; 2014 Aug; 34(4):353-9. PubMed ID: 24612240
[TBL] [Abstract][Full Text] [Related]
8. Heterogenous amplification of myc family oncogenes in small cell lung carcinoma.
Noguchi M; Hirohashi S; Hara F; Kojima A; Shimosato Y; Shinkai T; Tsuchiya R
Cancer; 1990 Nov; 66(10):2053-8. PubMed ID: 2171744
[TBL] [Abstract][Full Text] [Related]
9. CBX7 reprograms metabolic flux to protect against meningioma progression by modulating the USP44/c-MYC/LDHA axis.
Cheng H; Hua L; Tang H; Bao Z; Xu X; Zhu H; Wang S; Jiapaer Z; Bhatia R; Dunn IF; Deng J; Wang D; Sun S; Luan S; Ji J; Xie Q; Yang X; Lei J; Li G; Wang X; Gong Y
J Mol Cell Biol; 2024 Apr; 15(10):. PubMed ID: 37791390
[TBL] [Abstract][Full Text] [Related]
10. Malignant rhabdoid meningioma arising in the setting of preexisting ganglioglioma: a diagnosis supported by fluorescence in situ hybridization. Case report.
Bannykh SI; Perry A; Powell HC; Hill A; Hansen LA
J Neurosurg; 2002 Dec; 97(6):1450-5. PubMed ID: 12507148
[TBL] [Abstract][Full Text] [Related]
11. Melanocytic colonization of a meningothelial meningioma: histopathological and ultrastructural findings with immunohistochemical and genetic correlation: case report.
Nestor SL; Perry A; Kurtkaya O; Abell-Aleff P; Rosemblat AM; Burger PC; Scheithauer BW
Neurosurgery; 2003 Jul; 53(1):211-4; discussion 214-5. PubMed ID: 12823892
[TBL] [Abstract][Full Text] [Related]
12. Low-level amplification of oncogenes correlates inversely with age for patients with nontypical meningiomas.
Beckner ME; Sampath R; Flowers AB; Katira K; D'Souza D; Patil S; Patel RB; Nordberg ML; Nanda A
World Neurosurg; 2013 Feb; 79(2):313-9.e1-10. PubMed ID: 22120298
[TBL] [Abstract][Full Text] [Related]
13. PS6K amplification characterizes a small subset of anaplastic meningiomas.
Cai DX; James CD; Scheithauer BW; Couch FJ; Perry A
Am J Clin Pathol; 2001 Feb; 115(2):213-8. PubMed ID: 11211609
[TBL] [Abstract][Full Text] [Related]
14. Chromosomal and genetic abnormalities in benign and malignant meningiomas using DNA microarray.
Wada K; Maruno M; Suzuki T; Kagawa N; Hashiba T; Fujimoto Y; Hashimoto N; Izumoto S; Yoshimine T
Neurol Res; 2005 Oct; 27(7):747-54. PubMed ID: 16197812
[TBL] [Abstract][Full Text] [Related]
15. Cytogenetic findings in typical and atypical meningioma.
Meloni A; Morgan R; Bridge J; Erling MA; Lewin RJ; Sandberg AA
Cancer Genet Cytogenet; 1991 Jan; 51(1):35-9. PubMed ID: 1984845
[TBL] [Abstract][Full Text] [Related]
16. CNS Resident Award. Malignant meningiomas frequently lose multiple chromosomal regions in addition to 22q: putative meningioma progression loci identified by comparative genomic hybridization.
Metzger AK; Minn YA; Lieberman D; Bollen AW; Wilson CB; Feuerstein BG
Clin Neurosurg; 1999; 45():6-7. PubMed ID: 10461493
[No Abstract] [Full Text] [Related]
17. Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea.
Schrell UM; Rittig MG; Anders M; Koch UH; Marschalek R; Kiesewetter F; Fahlbusch R
J Neurosurg; 1997 May; 86(5):840-4. PubMed ID: 9126900
[TBL] [Abstract][Full Text] [Related]
18. [Early recurrent meningioma with malignant transformation: case report].
Nakatsuka H; Ohue S; Ohta S; Nakagawa K; Fukumoto SY; Kumon Y; Ohnishi T
No Shinkei Geka; 2003 Feb; 31(2):181-6. PubMed ID: 12616654
[TBL] [Abstract][Full Text] [Related]
19. Nasoethmoidal meningioma with cytogenetic features of tumor aggressiveness in a 16-year-old child.
Ketter R; Henn W; Feiden W; Prowald A; Sittel C; Steudel WI; Strowitzki M
Pediatr Neurosurg; 2003 Oct; 39(4):190-4. PubMed ID: 12944699
[TBL] [Abstract][Full Text] [Related]
20. Mutational Analysis of Recurrent Meningioma Progressing From Atypical to Rhabdoid Subtype.
Bujko M; Machnicki MM; Grecka E; Rusetska N; Matyja E; Kober P; Mandat T; Rydzanicz M; Płoski R; Krajewski R; Bonicki W; Stokłosa T; Siedlecki JA
World Neurosurg; 2017 Jan; 97():754.e1-754.e6. PubMed ID: 27756662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
